AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights:
Universal Ibogaine operates in the healthcare sector and is listed on the TSX Venture Composite and TSX Smallcap Indexes.
Recent reports have reviewed the company's balance sheet structure.
Key financial components include current liabilities, available assets, and financing history.
Universal Ibogaine (TSXV:IBO) is part of the healthcare sector with a listing on the TSX Venture Exchange. It is also included in the TSX Venture Composite Index (JX) and the TSX Smallcap Index (TXTW). The company focuses on treatment-centered services related to addiction recovery and therapeutic support, offering programs and initiatives targeting public health concerns.
Overview of Financial Structure
Recent coverage of Universal Ibogaine addressed components of the company’s financial structure. These observations noted the presence of current liabilities and available assets as indicators of operational status. Capital accessibility, debt positioning, and equity structure were discussed in the context of financial continuity. The organization’s balance sheet has been a point of interest due to its role in sustaining current business models.
Assets and Liabilities Review
Universal Ibogaine’s assets comprise cash equivalents, receivables, and intangible program-related items. These are weighed against current obligations, which include payables and other short-term liabilities. The data reflected in public filings serves as the basis for understanding the company’s ability to maintain liquidity in line with ongoing commitments.
Equity and Financial Movements
Historically, the company has recorded instances of external funding and adjustments in shareholder equity. Capital contributions have been structured across financing rounds. These activities are conducted in accordance with exchange rules and are reflected in periodic updates filed with the appropriate market authorities.
Index Classification and Market Position
As a constituent of the TSX Venture Composite Index (JX) and TSX Smallcap Index (TXTW), Universal Ibogaine is positioned among smaller public issuers focused on innovation and sector-specific services. Its listing in these indexes provides exposure within institutional monitoring systems while aligning the company with peers in early-stage healthcare offerings. These placements support visibility in Canada’s junior equity ecosystem.
